Sorry, you need to enable JavaScript to visit this website.

Immunomodulatory activity of biological and biotecnological products of industrial relevance

In recent years, the development of new drugs benefits from the open innovation model that sees Research Institutions and industries to share skills and know-how. Immunology is one of the most interesting areas for biotech and pharmaceutical industries. ENEA has skills, knowledge and experimental models that can provide support to pharmaceutical companies and other industry stakeholders in the development of immunomodulatory drugs using and/or developing innovative assays shifted from basic research. ENEA also supports technology transfer to companies where, assays developed by ENEA, can be implemented by adhering to GLP and/or GMP procedures.
ENEA provides support activities to companies for evaluation of products for the immunoregulation and immunotherapy. Collaborations with pharmaceutical and CRO companies are ongoing and/or have already been carried out to evaluate the activity of biological and biotechnological products as well as of small synthetic molecules for the modulation of immune functions using in vitro systems and in vivo and pre-clinical models.